Company Video
Dorrapharma is
engaged in R&D, manufacture and market of intermediates, APls (Active
Pharmaceutical Ingredients) and formulations. We own the core technology
advantage in the professional area of bromination, enzyme/metalcatalyzed,
nitration and hydrogenation, and obtain multiple core patents for invention. We
stick to raising the value both for the company and customers, and devote
ourselves completely to the technology innovation and brand build and make
every effort to foster the core competence for the company with the company
mission of a leading pharmaceutical integrated operator with its core
competitive advantage in global market.
Nanjing Dorra Pharmaceutical Technology Co.,Ltd.
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:2
-
Employees:50 - 99
Other Content from Nanjing Dorra Pharmaceutical Technology Co.,Ltd. (2)
-
News CEP of Fosfomycin Trometamol Newly Authorized!
We are proud to announce that our Fosfomycin Trometamol API has officially received EU CEP certification (Certificate No. 2024-168-Rev00) from the EDQM.We warmly invite global partners to connect with us and explore new avenues for collaboration. -
Brochure Dorra Product Lists
Commercialized and Under-Development Pipline